The UK government has launched the new UK Life Sciences Vision, a 10-year strategy through which it aims to work with the country’s life sciences sector to tackle some of the biggest current healthcare problems and accelerate the delivery of life sciences innovations to UK patients.

The mission-led plan will seek to build on the UK life sciences sector’s widely-praised response to the COVID-19 pandemic and will be supported by the new £200 million Life Sciences Investment Programme, which will bring the total funding available to UK life sciences firms to £1 billion.

The Life Sciences Vision was co-developed by the government alongside businesses and experts and has outlined seven key healthcare missions which the government and life sciences industry will work to solve alongside the NHS, academia and charities.

The critical missions are: accelerating studies into dementia treatment; enabling early diagnosis and treatment; sustaining the UK’s position in the discovery, development and manufacture of vaccines; treatment and prevention of cardiovascular disease and its risk factors; reducing the mortality of respiratory disease; addressing the biology of ageing; increasing understanding of mental health conditions.

Life Sciences Minister Nadhim Zahawi commented: “Through this pandemic, we have turned to the brilliance of our UK life sciences sector which time after time has stepped up and done the country proud – from developing life-saving vaccines to identifying variants through world class genome sequencing.”

“We want to bottle up this scientific brilliance, and the Life Sciences Vision provides a roadmap for how we apply this innovation at the heart of our NHS helping to solve major health challenges such as dementia and obesity – all while ensuring the UK remains a global leader in life sciences.”

Contact us


Tel: +44 (0)1424 777745

Fax: +44 (0)1424 777746



Kirkham Young Ltd.
The Old Court House
North Trade Road
East Sussex
TN33 0EX